Fractyl Health’s GLP-1 gene therapy trial given green light
Fractyl Health’s trial to evaluate a glucagon-like peptide-1 (GLP-1) gene therapy has been approved by European authorities. The open-label, first-in-human,…
News
WhiteSwell’s heart failure device promising but patient death rattles results
FDA locks down post-approval pregnancy safety data framework
Actio Biosciences begins trial of ABS-1230 for epilepsy
Day One concludes patient enrolment for tovorafenib’s FIREFLY-2 trial
Beacon Therapeutics’ gene therapy shows 12-month benefit
enGene reports interim data from LEGEND trial of detalimogene voraplasmid
Entrada’s stock drops as DMD drug’s efficacy falls short
